The diagnostic value of PET/CT imaging with the 68Ga-labeled PSMA-ligand in the follow up assessment of prostate cancer after therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2090-4762
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The diagnostic value of PET/CT imaging with the 68Ga-labeled PSMA-ligand in the follow up assessment of prostate cancer after therapy ; volume:51 ; number:1 ; day:23 ; month:7 ; year:2020 ; pages:1-9 ; date:12.2020
The Egyptian Journal of Radiology and Nuclear Medicine ; 51, Heft 1 (23.7.2020), 1-9, 12.2020
- Creator
-
Hassan, Talaat Ahmed Abd El Hameed
Elazab, Mohammed Samy
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43055-020-00259-2
- URN
-
urn:nbn:de:101:1-2020091620134654087121
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hassan, Talaat Ahmed Abd El Hameed
- Elazab, Mohammed Samy
- SpringerLink (Online service)
Other Objects (12)
![Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007](/assets/placeholder/searchResultMediaUnknown.png)
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma
68Ga-PSMA and 68Ga-FAPI radioligands in the diagnosis of tumors
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
The value of 68Ga-PSMA PET/CT in the diagnosis of intracapsular prostate cancer with a poor prognosis
Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
Cost-effectiveness of the implementation of [68Ga]Ga-PSMA-11 PET/CT at initial prostate cancer staging
68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]
Stellenwert der 68Ga-PSMA-11 PET/CT bei Patienten mit bioptisch gesichertem Prostatakarzinom
Evaluating the biodistribution for [68Ga]Ga-PSMA-11 and [18F]F-PSMA-1007 PET/CT with an inter- and intrapatient based analysis
Preparation and PET/CT imaging of implant directed 68Ga-labeled magnetic nanoporous silica nanoparticles
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma
68Ga-PSMA and 68Ga-FAPI radioligands in the diagnosis of tumors
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
The value of 68Ga-PSMA PET/CT in the diagnosis of intracapsular prostate cancer with a poor prognosis
Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
Cost-effectiveness of the implementation of [68Ga]Ga-PSMA-11 PET/CT at initial prostate cancer staging
68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]
Stellenwert der 68Ga-PSMA-11 PET/CT bei Patienten mit bioptisch gesichertem Prostatakarzinom
Evaluating the biodistribution for [68Ga]Ga-PSMA-11 and [18F]F-PSMA-1007 PET/CT with an inter- and intrapatient based analysis
Preparation and PET/CT imaging of implant directed 68Ga-labeled magnetic nanoporous silica nanoparticles
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma
68Ga-PSMA and 68Ga-FAPI radioligands in the diagnosis of tumors
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
The value of 68Ga-PSMA PET/CT in the diagnosis of intracapsular prostate cancer with a poor prognosis
Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
Cost-effectiveness of the implementation of [68Ga]Ga-PSMA-11 PET/CT at initial prostate cancer staging
68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]
Stellenwert der 68Ga-PSMA-11 PET/CT bei Patienten mit bioptisch gesichertem Prostatakarzinom
Evaluating the biodistribution for [68Ga]Ga-PSMA-11 and [18F]F-PSMA-1007 PET/CT with an inter- and intrapatient based analysis